2-38075218-C-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000104.4(CYP1B1):​c.171G>A​(p.Trp57*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 1,582,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00042 ( 0 hom. )

Consequence

CYP1B1
NM_000104.4 stop_gained

Scores

2
4
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:14

Conservation

PhyloP100: 3.28
Variant links:
Genes affected
CYP1B1 (HGNC:2597): (cytochrome P450 family 1 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 167 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-38075218-C-T is Pathogenic according to our data. Variant chr2-38075218-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 7737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-38075218-C-T is described in Lovd as [Pathogenic]. Variant chr2-38075218-C-T is described in Lovd as [Likely_pathogenic]. Variant chr2-38075218-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CYP1B1NM_000104.4 linkuse as main transcriptc.171G>A p.Trp57* stop_gained 2/3 ENST00000610745.5 NP_000095.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CYP1B1ENST00000610745.5 linkuse as main transcriptc.171G>A p.Trp57* stop_gained 2/31 NM_000104.4 ENSP00000478561.1 Q16678

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152254
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000173
AC:
35
AN:
201850
Hom.:
0
AF XY:
0.000181
AC XY:
20
AN XY:
110788
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000330
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000374
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000417
AC:
597
AN:
1430468
Hom.:
0
Cov.:
36
AF XY:
0.000390
AC XY:
277
AN XY:
709858
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.0000242
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000513
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000249
Gnomad4 NFE exome
AF:
0.000526
Gnomad4 OTH exome
AF:
0.000151
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152254
Hom.:
0
Cov.:
34
AF XY:
0.000255
AC XY:
19
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.0000723
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000441
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000341
Hom.:
0
Bravo
AF:
0.000227
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000465
AC:
2
ESP6500EA
AF:
0.000237
AC:
2
ExAC
AF:
0.000194
AC:
23

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Anterior segment dysgenesis 6 Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingMolecular Diagnostics Laboratory, M Health Fairview: University of MinnesotaAug 25, 2021- -
Pathogenic, no assertion criteria providedliterature onlyOMIMMay 01, 2001- -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsMar 27, 2024- -
not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingGeneDxJan 10, 2023Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 14635112, 11403040, 16735994, 30653986, 23218701, 24281366, 27820421, 34758253, 12525557, 19643970, 17718864, 23922489, 27777502, 12036985, 26689913, 31980526, 31589614, 32499604, 22004014, 35170016) -
Pathogenic, criteria provided, single submitterclinical testingClinical Genetics Laboratory, Skane University Hospital LundMay 27, 2022- -
Likely pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityDec 16, 2020- -
Glaucoma 3A Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 26, 2013The Trp57X variant in CYP1B1 has been previously identified in 1 compound heterozygous individual with Peter's anomaly and secondary congenital glaucoma (Vincent 2001), in 1 heterozygous individual with primary open angle glaucoma (Pasutto 2010), in 1 heterozygous patient with pseudoexfoliative glaucoma (Patel 2012), and was found to segregate with disease in 1 affected relative with primary open angle glaucoma (Patel 2012). This variant has been identified in 2/8428 of European American chromosomes and 2/4298 of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs72549387). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This nonsense variant leads to a premature termination codon at position 57, which is predicted to lead to a truncated or absent protein. In summary, this variant meets our criteria to be classified as pathogenic in a recessive manner for primary congenital glaucoma. In addition, one study reported an association between carrier status for pathogenic CYP1B1 variants and risk for adult-onset primary open angle glaucoma (Pasutto 2010). However, this study has not been replicated. -
Pathogenic, criteria provided, single submitterclinical testingGenomics England Pilot Project, Genomics England-- -
CYP1B1-related disorder Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017The CYP1B1 c.171G>A (p.Trp57Ter) variant is a stop-gained variant. Across a selection of the available literature, the p.Trp57Ter variant has been reported in at least seven studies in which it was found in a compound heterozygous state in four individuals with Peters anomaly and six individuals with primary congenital glaucoma (including one set of twins), and in a heterozygous state in one individual with pseudoexfoliative glaucoma and two individuals with with juvenile open angle glaucoma, both of whom carried additional variants in another gene. The variant was also reported in a heterozygous state in three unaffected individuals (Vincent et al. 2001; Stoilov et al. 2002; Pasutto et al. 2010; Patel et al. 2012; Lim et al. 2013; Milla et al. 2013; Prokudin et al. 2014). The p.Trp57Ter variant was found in a heterozygous state in three of 1190 control alleles and is reported at a frequency of 0.00072 in the European (non-Finnish) population of the Exome Aggregation Consortium. Due to the potential impact of stop-gained variants and the collective evidence, the p.Trp57Ter variant is classified as pathogenic for CYP1B1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 17, 2024The CYP1B1 c.171G>A variant is predicted to result in premature protein termination (p.Trp57*). This variant has been reported in the compound heterozygous state in individuals with Peter's anomaly or congenital glaucoma (Vincent et al. 2001. PubMed ID: 11403040; Prokudin et al. 2013. PubMed ID: 24281366; Grønskov et al 2016. PubMed ID: 27820421; Millá et al. 2013. PubMed ID: 23922489), and in the heterozygous state in individuals with primary open angle glaucoma (Pasutto et al. 2010. PubMed ID: 19643970; Patel et al. 2012. PubMed ID: 22004014). This variant is reported in 0.039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in CYP1B1 are expected to be pathogenic. Given the evidence, this variant is interpreted as pathogenic for autosomal recessive disease; additionally this variant may confer a risk for the development of primary open angle glaucoma. -
Anterior segment dysgenesis Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingEye Genetics Research Group, Children's Medical Research InstituteMar 31, 2020- -
Glaucoma 3, primary infantile, B;C1856439:Glaucoma 3A;C4310623:Anterior segment dysgenesis 6 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Irido-corneo-trabecular dysgenesis Pathogenic:1
Pathogenic, no assertion criteria providedresearchEye Genetics Research Group, Children's Medical Research InstituteMar 30, 2012- -
Congenital glaucoma Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 16, 2024This sequence change creates a premature translational stop signal (p.Trp57*) in the CYP1B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP1B1 are known to be pathogenic (PMID: 9097971, 9497261, 19234632). This variant is present in population databases (rs72549387, gnomAD 0.04%). This premature translational stop signal has been observed in individuals with primary congenital glaucoma and primary open angle glaucoma and Peter's anomaly (PMID: 11403040, 12036985, 19643970, 22004014, 23218701, 23922489, 24281366, 27820421). ClinVar contains an entry for this variant (Variation ID: 7737). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.40
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
42
DANN
Uncertain
0.99
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.91
D
Vest4
0.76
GERP RS
4.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72549387; hg19: chr2-38302361; API